Ilya Pharma

Uppsala, Sweden Founded: 2016 • Age: 10 yrs
Biological drugs for skin and mucosa wound treatment are developed.
Request Access

About Ilya Pharma

Ilya Pharma is a company based in Uppsala (Sweden) founded in 2016 by Mia Phillipson and Stefan Roos.. Ilya Pharma has raised $4.02 million across 6 funding rounds from investors including EIT Health, European Union and EIC Fund. Ilya Pharma offers products and services including ILP100-Topical and ILP100-Oral.

  • Headquarter Uppsala, Sweden
  • Founders Mia Phillipson, Stefan Roos
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ilya Pharma Ab
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $1.12 M (USD)
    433
    as on Dec 31, 2021
  • Net Profit
    $-6.78 M (USD)
    -24
    as on Dec 31, 2021
  • EBITDA
    $-6.78 M (USD)
    -24
    as on Dec 31, 2021
  • Total Equity Funding
    $4.02 M (USD)

    in 6 rounds

  • Latest Funding Round
    $1.6 M (USD), Grant

    Oct 01, 2020

  • Investors
    EIT Health

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ilya Pharma

Ilya Pharma offers a comprehensive portfolio of products and services, including ILP100-Topical and ILP100-Oral. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A therapy is utilized for healing wounds in immunocompromised patients by employing genetically modified bacteria.

A treatment is applied for colitis in cancer patients through the use of live bacteria as local bioreactors.

Funding Insights of Ilya Pharma

Ilya Pharma has successfully raised a total of $4.02M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.6 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Grant — $1.6M
  • First Round

    (10 Jul 2017)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2020 Amount Grant - Ilya Pharma Valuation

investors

Jul, 2020 Amount Grant - Ilya Pharma Valuation

investors

Sep, 2018 Amount Series A - Ilya Pharma Valuation EIC Fund
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ilya Pharma

Ilya Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Healthcare startups are accelerated and incubated through specialized programs.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ilya Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ilya Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ilya Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ilya Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ilya Pharma

Frequently Asked Questions about Ilya Pharma

When was Ilya Pharma founded?

Ilya Pharma was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Ilya Pharma located?

Ilya Pharma is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.

Is Ilya Pharma a funded company?

Ilya Pharma is a funded company, having raised a total of $4.02M across 6 funding rounds to date. The company's 1st funding round was a Series A of $3.48M, raised on Jul 10, 2017.

What is the annual revenue of Ilya Pharma?

Annual revenue of Ilya Pharma is $1.12M as on Dec 31, 2021.

What does Ilya Pharma do?

Ilya Pharma, a biopharma company, was founded in 2016 in Uppsala, Sweden. Biological drugs for acute and chronic wounds, including those in diabetic patients, are developed using human therapeutic proteins delivered by living lactic acid bacteria. The formulation is stored freeze-dried and revived with water prior to use. Focus is placed on skin and mucosa indications within the therapeutics sector.

What products or services does Ilya Pharma offer?

Ilya Pharma offers ILP100-Topical and ILP100-Oral.

Who are Ilya Pharma's investors?

Ilya Pharma has 4 investors. Key investors include EIT Health, European Union, EIC Fund, and Professionell Ägarstyrning.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available